Collectively, our findings provided strong evidence supporting the anti-angiogenic activities of crocetin and crocin, and indicated that crocetin had more anti-angiogenic and anti-VEGF therapeutic value for AMD. This evidence concerns the gene VEGFA and age-related macular degeneration.